Professor Pam Kearns, Director of the Cancer Research UK Clinical Trials Unit,  University of Birmingham  
 
The CATALYST trial: Accelerating drug development for COVID-19

Transcript: https://docs.google.com/document/d/1h5c5C15kiTqsPEJPoHXkbcDTD_hbhIBNzSQjQavteLk/edit?usp=sharing

Professor Pam Kearns - The CATALYST trial: Accelerating drug development for COVID-19

The National Institute for Health and Care Research (NIHR): funding, enabling and delivering world-class health and care research that transforms people's lives. Visit our website: www.nihr.ac.uk

For our latest podcasts please visit our new page: https://www.buzzsprout.com/1833774/episodes